The requirement for proteomics to unravel stem cell regulatory mechanisms

Journal of Cellular Physiology

Volumn 226, Issue 10, 2011, Pages 2478-2483

  Williamson, Andrew J K ^a   Whetton, Anthony D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; TRANSCRIPTION FACTOR;

ACETYLATION; CANCER STEM CELL; CELL DIFFERENTIATION; CELL TYPE; EMBRYO CELL; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION; HUMAN; METHYLATION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REGULATORY MECHANISM; SHORT SURVEY; STEM CELL; UBIQUITINATION;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CHROMATOGRAPHY, LIQUID; HUMANS; PLURIPOTENT STEM CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 79960673730     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22610     Document Type: Short Survey

References (112)

1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, Tiscornia G, Edel M, Boue S, Izpisua Belmonte JC. 2008. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276-1284.
2. Ahn SM, Goode RJA, Simpson RJ. 2008. Stem cell markers: Insights from membrane proteomics? Proteomics 8: 4946-4957.
3. Andersen JS, Matic I, Vertegaal AC. 2009. Identification of SUMO target proteins by quantitative proteomics. Methods Mol Biol 497: 19-31.
4. Anderson L, Seilhamer J. 1997. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18: 533-537.
5. Andersson L, Porath J. 1986. Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography. Anal Biochem 154: 250-254.
6. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S. 2008. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321: 699-702.
7. Baharvand H, Hajheidari M, Ashtiani SK, Salekdeh GH. 2006. Proteomic signature of human embryonic stem cells. Proteomics 6: 3544-3549.
8. Blelloch R. 2008. Regenerative medicine: Short cut to cell replacement. Nature 455: 604-605.
9. Bodenmiller B, Mueller LN, Mueller M, Domon B, Aebersold R. 2007. Reproducible isolation of distinct, overlapping segments of the phosphoproteome. Nat Methods 4: 231-237.
10. Boersema PJ, Foong LY, Ding VM, Lemeer S, van Breukelen B, Philp R, Boekhorst J, Snel B, den Hertog J, Choo AB, Heck AJ. 2009. In-depth qualitative and quantitative profiling of tyrosine phosphorylation using a combination of phosphopeptide immunoaffinity purification and stable isotope dimethyl labeling. Mol Cell Proteomics 9: 84-99.
11. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956.
12. Brill LM, Xiong W, Lee KB, Ficarro SB, Crain A, Xu Y, Terskikh A, Snyder EY, Ding S. 2009. Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell 5: 204-213.
13. Cancelas JA, Williams DA. 2009. Rho GTPases in hematopoietic stem cell functions. Curr Opin Hematol 16: 249-254.
14. Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, Yang L, Kaplan AD, Adler ED, Rozov R, Ge Y, Cohen N, Edelmann LJ, Chang B, Waghray A, Su J, Pardo S, Lichtenbelt KD, Tartaglia M, Gelb BD, Lemischka IR. 2010. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465: 808-812.
15. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
16. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, Robertson M, Vrana J, Jones K, Grotewold L, Smith A. 2007. Nanog safeguards pluripotency and mediates germline development. Nature 450: 1230-1234.
17. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, Loh YH, Yeo HC, Yeo ZX, Narang V, Govindarajan KR, Leong B, Shahab A, Ruan Y, Bourque G, Sung WK, Clarke ND, Wei CL, Ng HH. 2008. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133: 1106-1117.
18. Choi MY, An YJ, Kim SH, Roh SH, Ju HK, Hong SS, Park JH, Ch KJ, Choi DW, Kwon SW. 2007. Mass spectrometry based proteomic analysis of human stem cells: A brief review. Exp Mol Med 39: 690-695.
19. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, Zhao K. 2009. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4: 80-93.
20. D'Alessandro A, Liumbruno G, Grazzini G, Pupella S, Lombardini L, Zolla L. 2009. Umbilical cord blood stem cells: Towards a proteomic approach. J Proteomics 73: 468-482.
21. Deleyrolle LP, Reynolds BA. 2009. Isolation, expansion, and differentiation of adult Mammalian neural stem and progenitor cells using the neurosphere assay. Methods Mol Biol 549: 91-101.
22. Dormeyer W, van Hoof D, Mummery CL, Krijgsveld J, Heck AJR. 2008. A practical guide for the identification of membrane and plasma membrane proteins in human embryonic stem cells and human embryonal carcinoma cells. Proteomics 8: 4036-4053.
23. Eramo A, Haas TL, De Maria R. 2010. Lung cancer stem cells: Tools and targets to fight lung cancer. Oncogene 29: 4625-4635.
24. Fathi A, Pakzad M, Taei A, Brink TC, Pirhaji L, Ruiz G, Bordbar MST, Gourabi H, Adjaye J, Baharvand H, Salekdeh GH. 2009. Comparative proteome and transcriptome analyses of embryonic stem cells during embryoid body-based differentiation. Proteomics 9: 4859-4870.
25. Feldmann RE, Bieback K, Maurer MH, Kalenka A, Burgers HF, Gross B, Hunzinger C, Kluter H, Kuschinsky W, Eichler H. 2005. Stem cell proteomes: A profile of human mesenchymal stem cells derived from umbilical cord blood. Electrophoresis 26: 2749-2758.
26. Garcia BA, Shabanowitz J, Hunt DF. 2007. Characterization of histones and their post-translational modifications by mass spectrometry. Curr Opin Chem Biol 11: 66-73.
27. Gauci S, Helbig AO, Slijper M, Krijgsveld J, Heck AJ, Mohammed S. 2009. Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem 81: 4493-4501.
28. Graumann J, Hubner NC, Kim JB, Ko K, Moser M, Kumar C, Cox J, Scholer H, Mann M. 2008. Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5, 111 proteins. Mol Cell Proteomics 7: 672-683.
29. Griffiths SD, Burthem J, Unwin RD, Holyoake TL, Melo JV, Lucas GS, Whetton AD. 2007. The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia. Mol Biotechnol 36: 81-89.
30. Gundry RL, Boheler KR, Van Eyk JE, Wollscheid B. 2008. A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface. Proteomics Clin Appl 2: 892-903.
31. Gundry RL, Tchernyshyov I, Sheng S, Tarasova Y, Raginski K, Boheler KR, Van Eyk JE. 2010. Expanding the mouse embryonic stem cell proteome: Combining three proteomic approaches. Proteomics 10: 2728-2732.
32. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999.
33. Hailesellasse Sene K, Porter CJ, Palidwor G, Perez-Iratxeta C, Muro EM, Campbell PA, Rudnicki MA, Andrade-Navarro MA. 2007. Gene function in early mouse embryonic stem cell differentiation. BMC Genomics 8: 85.
34. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R. 2008. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133: 250-264.
35. Harkness L, Christiansen H, Nehlin J, Barington T, Andersen JS, Kassem M. 2008. Identification of a membrane proteomic signature for human embryonic stem cells independent of culture conditions. Stem Cell Res 1: 219-227.
36. Hunter T, Cooper JA. 1985. Protein-tyrosine kinases. Annu Rev Biochem 54: 897-930.
37. Intoh A, Kurisaki A, Yamanaka Y, Hirano H, Fukuda H, Sugino H, Asashima M. 2009. Proteomic analysis of membrane proteins expressed specifically in pluripotent murine embryonic stem cells. Proteomics 9: 126-137.
38. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. 2002. A stem cell molecular signature. Science 298: 601-604.
39. Jaenisch R, Young R. 2008. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132: 567-582.
40. Ji YH, Ji JL, Sun FY, Zeng YY, He XH, Zhao JX, Yu Y, Yu SH, Wu W. 2010. Quantitative proteomics analysis of chondrogenic differentiation of C3H10T1/2 mesenchymal stem cells by iTRAQ labeling coupled with on-line two-dimensional LC/MS/MS. Mol Cell Proteomics 9: 550-564.
41. Jung HR, Pasini D, Helin K, Jensen ON. 2010. Quantitative mass spectrometry of histones H3.2 and H3.3 in Suz12-deficient mouse embryonic stem cells reveals distinct, dynamic post-translational modifications at Lys-27 and Lys-36. Mol Cell Proteomics 9: 838-850.
42. Kim J, Chu J, Shen X, Wang J, Orkin SH. 2008a. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132: 1049-1061.
43. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Arauzo-Bravo MJ, Ruau D, Han DW, Zenke M, Scholer HR. 2008b. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454: 646-650.
44. Kim S, Min WK, Chun S, Lee W, Chung HJ, Choi SJ, Yang SE, Yang YS, Yoo JI. 2010. Protein expression profiles during osteogenic differentiation of mesenchymal stem cells derived from human umbilical cord blood. Tohoku J Exp Med 221: 141-150.
45. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128: 693-705.
46. Krijgsveld J. 2006. Proteomics of differentiating embryonic stem cells. Mol Cell Proteomics 5: 579.
47. Kurpinski K, Chu J, Wang DJ, Li S. 2009. Proteomic profiling of mesenchymal stem cell responses to mechanical strain and TGF-beta 1. Cell Mol Bioeng 2: 606-614.
48. Kweon HK, Hakansson K. 2006. Selective zirconium dioxide-based enrichment of phosphorylated peptides for mass spectrometric analysis. Anal Chem 78: 1743-1749.
49. Lee CF, Griffiths S, Rodriguez-Suarez E, Pierce A, Unwin RD, Jaworska E, Evans CA, Gaskell SJ, Whetton AD. 2010. Assessment of downstream effectors of BCR/ABL protein tyrosine kinase using combined proteomic approaches. Proteomics 10: 3321-3342.
50. Li N, Sarojini H, An J, Wang E. 2010. Prosaposin in the secretome of marrow stroma-derived neural progenitor cells protects neural cells from apoptotic death. J Neurochem 112: 1527-1538.
51. Liu H, Zhu F, Yong J, Zhang P, Hou P, Li H, Jiang W, Cai J, Liu M, Cui K, Qu X, Xiang T, Lu D, Chi X, Gao G, Ji W, Ding M, Deng H. 2008a. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 3: 587-590.
52. Liu X, Huang J, Chen T, Wang Y, Xin S, Li J, Pei G, Kang J. 2008b. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells. Cell Res 18: 1177-1189.
53. Liu XY, Ren XF, Deng XY, Huo YA, Xie J, Huang H, Jiao Z, Wu MH, Liu YF, Wen TQ. 2010. A protein interaction network for the analysis of the neuronal differentiation of neural stem cells in response to titanium dioxide nanoparticles. Biomaterials 31: 3063-3070.
54. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH. 2006. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38: 431-440.
55. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K. 2008. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105: 2883-2888.
56. Lu R, Markowetz F, Unwin RD, Leek JT, Airoldi EM, MacArthur BD, Lachmann A, Rozov R, Ma'ayan A, Boyer LA, Troyanskaya OG, Whetton AD, Lemischka IR. 2009. Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 462: 358-362.
57. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K. 2007. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70.
58. Mak AB, Ni Z, Hewel JA, Chen GI, Zhong G, Karamboulas K, Blakely K, Smiley S, Marcon E, Roudeva D, Li J, Olsen JB, Wan C, Punna T, Isserlin R, Chetyrkin S, Gingras AC, Emili A, Greenblatt J, Moffat J. 2010. A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency. Mol Cell Proteomics 9: 811-823.
59. Mareddy S, Broadbent J, Crawford R, Xiao Y. 2009. Proteomic profiling of distinct clonal populations of bone marrow mesenchymal stem cells. J Cell Biochem 106: 776-786.
60. Maziarz M, Chung C, Drucker DJ, Emili A. 2005. Integrating global proteomic and genomic expression profiles generated from islet alpha cells: Opportunities and challenges to deriving reliable biological inferences. Mol Cell Proteomics 4: 458-474.
61. Mohammed S, Kraiczek K, Pinkse MW, Lemeer S, Benschop JJ, Heck AJ. 2008. Chip-based enrichment and nanoLC-MS/MS analysis of phosphopeptides from whole lysates. J Proteome Res 7: 1565-1571.
62. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. 2008. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953.
63. Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, Resing KA, Ahn NG. 2005. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 4: 1487-1502.
64. Olsen JV, Macek B. 2009. High accuracy mass spectrometry in large-scale analysis of protein phosphorylation. Methods Mol Biol 492: 131-142.
65. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. 2006. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127: 635-648.
66. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M. 2002. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386.
67. Palmisano G, Thingholm TE. 2010. Strategies for quantitation of phosphoproteomic data. Expert Rev Proteomics 7: 439-456.
68. Park HW, Shin JS, Kim CW. 2007. Proteome of mesenchymal stem cells. Proteomics 7: 2881-2894.
69. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
70. Pasini D, Malatesta M, Jung HR, Walfridsson J, Willer A, Olsson L, Skotte J, Wutz A, Porse B, Jensen ON, Helin K. 2010. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res 38: 4958-4969.
71. Peng J. 2008. Evaluation of proteomic strategies for analyzing ubiquitinated proteins. BMB Rep 41: 177-183.
72. Pera MF, Tam PP. 2010. Extrinsic regulation of pluripotent stem cells. Nature 465: 713-720.
73. Phanstiel D, Brumbaugh J, Berggren WT, Conard K, Feng X, Levenstein ME, McAlister GC, Thomson JA, Coon JJ. 2008. Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells. Proc Natl Acad Sci USA 105: 4093-4098.
74. Phu L, Izrael-Tomasevic A, Matsumoto ML, Bustos DJ, Dynek JN, Fedorova AV, Bakalarski CE, Arnott D, Deshayes K, Dixit VM, Kelley RF, Vucic D, Kirkpatrick DS. 2010. Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals. Mol Cell Proteomics Nov 3 [Epub ahead of print].
75. Pinkse MW, Uitto PM, Hilhorst MJ, Ooms B, Heck AJ. 2004. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal Chem 76: 3935-3943.
76. Posewitz MC, Tempst P. 1999. Immobilized gallium(III) affinity chromatography of phosphopeptides. Anal Chem 71: 2883-2892.
77. Price ND, Foltz G, Madan A, Hood L, Tian Q. 2008. Systems biology and cancer stem cells. J Cell Mol Med 12: 97-110.
78. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA. 2002. " Stemness": Transcriptional profiling of embryonic and adult stem cells. Science 298: 597-600.
79. Roche S, Provansal M, Tiers L, Jorgensen C, Lehmann S. 2006. Proteomics of primary mesenchymal stem cells. Regenerative Med 1: 511-517.
80. Roche S, Delorme B, Oostendorp RAJ, Barbet R, Caton D, Noel D, Boumediene K, Papadaki HA, Cousin B, Crozet C, Milhavet O, Casteilla L, Hatzfeld J, Jorgensen C, Charbord P, Lehmann S. 2009. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: Towards the definition of a mesenchymal stem cell proteomic signature. Proteomics 9: 223-232.
81. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ. 2004. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169.
82. Sano A, Nakamura H. 2004. Titania as a chemo-affinity support for the column-switching HPLC analysis of phosphopeptides: Application to the characterization of phosphorylation sites in proteins by combination with protease digestion and electrospray ionization mass spectrometry. Anal Sci 20: 861-864.
83. Schmidt C, Lenz C, Grote M, Luhrmann R, Urlaub H. 2010. Determination of protein stoichiometry within protein complexes using absolute quantification and multiple reaction monitoring. Anal Chem 82: 2784-2796.
84. Smith KT, Workman JL. 2009. Introducing the acetylome. Nature Biotechnol 27: 917-919.
85. Spooncer E, Brouard N, Nilsson SK, Williams B, Liu MC, Unwin RD, Blinco D, Jaworska E, Simmons PJ, Whetton AD. 2008. Developmental fate determination and marker discovery in hematopoietic stem cell biology using proteomic fingerprinting. Mol Cell Proteomics 7: 573-581.
86. Stadtfeld M, Brennand K, Hochedlinger K. 2008. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18: 890-894.
87. Steiniger SCJ, Coppinger JA, Kruger JA, Yates J, Janda KD. 2008. Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population. Stem Cells 26: 3037-3046.
88. Swaney DL, McAlister GC, Coon JJ. 2008. Decision tree-driven tandem mass spectrometry for shotgun proteomics. Nat Methods 5: 959-964.
89. Swaney DL, Wenger CD, Thomson JA, Coon JJ. 2009. Human embryonic stem cell phosphoproteome revealed by electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci USA 106: 995-1000.
90. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
91. Takahashi K, Okita K, Nakagawa M, Yamanaka S. 2007a. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2: 3081-3089.
92. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Takahashi K, Okita K, Nakagawa M, Yamanaka S. 2007b. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
93. Tie F, Banerjee R, Stratton CA, Prasad-Sinha J, Stepanik V, Zlobin A, Diaz MO, Scacheri PC, Harte PJ. 2009. CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development 136: 3131-3141.
94. Unwin RD, Whetton AD. 2006. Systematic proteome and transcriptome analysis of stem cell populations. Cell Cycle 5: 1587-1591.
95. Unwin RD, Whetton AD. 2007. How will haematologists use proteomics? Blood Rev 21: 315-326.
96. Unwin RD, Griffiths JR, Leverentz MK, Grallert A, Hagan IM, Whetton AD. 2005. Multiple reaction monitoring to identify sites of protein phosphorylation with high sensitivity. Mol Cell Proteomics 4: 1134-1144.
97. Unwin RD, Smith DL, Blinco D, Wilson CL, Miller CJ, Evans CA, Jaworska E, Baldwin SA, Barnes K, Pierce A, Spooncer E, Whetton AD. 2006. Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. Blood 107: 4687-4694.
98. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, Khalil A, Rheinwald JG, Hochedlinger K. 2009. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460: 1145-1148.
99. Van Hoof D, Mummery CL, Heck AJR, Krijgsveld J. 2006. Embryonic stem cell proteomics. Expert Rev Proteomics 3: 427-437.
100. Van Hoof D, Munoz J, Braam SR, Pinkse MWH, Linding R, Heck AJR, Mummery CL, Krijgsveld J. 2009. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 5: 214-226.
101. Van Laere S, Limame R, Van Marck EA, Vermeulen PB, Dirix LY. 2010. Is there a role for mammary stem cells in inflammatory breast carcinoma? A review of evidence from cell line, animal model, and human tissue sample experiments. Cancer 116: 2794-2805.
102. Vinatier C, Bouffi C, Merceron C, Gordeladze J, Brondello JM, Jorgensen C, Weiss P, Guicheux J, Noel D. 2009. Cartilage tissue engineering: Towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther 4: 318-329.
103. Wang JL, Orkin SH. 2008. A protein roadmap to pluripotency and faithful reprogramming. Cells Tissues Organs 188: 23-30.
104. Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y, Roeder RG, Clarke S, Stallcup MR, Allis CD, Coonrod SA. 2004. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306: 279-283.
105. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH. 2006. A protein interaction network for pluripotency of embryonic stem cells. Nature 444: 364-368.
106. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 105: 5856-5861.
107. Whetton AD, Unwin R, Griffiths JR, Pierce A, Smith D. 2005. Proteomics and hematopoiesis. Inflammat Res 54: S92-S92.
108. Williamson AJK, Smith DL, Blinco D, Unwin RD, Pearson S, Wilson C, Miller C, Lancashire L, Lacaud G, Kouskoff V, Whetton AD. 2008. Quantitative proteomics analysis demonstrates post-transcriptional regulation of embryonic stem cell differentiation to hematopoiesis. Mol Cell Proteomics 7: 459-472.
109. Wisniewski JR, Zougman A, Mann M. 2008. Nepsilon-formylation of lysine is a widespread post-translational modification of nuclear proteins occurring at residues involved in regulation of chromatin function. Nucleic Acids Res 36: 570-577.
110. Wu Z, Chen J, Ren J, Bao L, Liao J, Cui C, Rao L, Li H, Gu Y, Dai H, Zhu H, Teng X, Cheng L, Xiao L. 2009. Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol 1: 46-54.
111. Xie W, Song C, Young NL, Sperling AS, Xu F, Sridharan R, Conway AE, Garcia BA, Plath K, Clark AT, Grunstein M. 2009. Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell 33: 417-427.
112. Xu H, Schaniel C, Lemischka IR, Ma'ayan A. 2010. Toward a complete in silico, multi-layered embryonic stem cell regulatory network. Wiley Interdiscip Rev Syst Biol Med 2: 708-733.